Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway
Doha Reda, Gehad E. Elshopakey, Talat A. Albukhari, Samah J. Almehmadi, Bassem Refaat, E. Risha, Hebatallah A. Mahgoub, Mohamed E. El-Boshy, F. Abdelhamid
Frontiers in Pharmacology